On Monday at 10:53 AM (Bangkok time), the share price of Bumrungrad Hospital Public Company Limited (SET: BH) gained 1.97% or THB 3.50 to THB 181.50, with a trading value of THB 1.22 billion.
DBS Vickers Securities (Thailand) (DBSV) has stated that the resolution of the conflict between the United States and Iran is a positive factor for BH, as it will support the recovery of international patient numbers, particularly patients from the Middle East—a key market for the company.
In the first quarter of 2026, revenue from Middle Eastern patients grew by 21% compared to the same period last year, accounting for 22% of BH’s total international patient revenue. Meanwhile, revenue from patients from Myanmar and Bangladesh increased by 15% and 25%, respectively.
The company’s foreign patient revenue constitutes as much as 66% of its total revenue. According to the brokerage, BH’s financial performance is likely to further improve, driven by the recovery of international patients and effective cost and expense management.
As a result, DBSV maintains a ‘Buy’ recommendation on BH, with a target price of THB 200 per share.
